[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Paclitaxel Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

April 2024 | 134 pages | ID: G4FE298A8CC2EN
APO Research

US$ 3,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it 'taxol'.

According to APO Research, The global Paclitaxel market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.

This report presents an overview of global market for Paclitaxel, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Paclitaxel, also provides the sales of main regions and countries. Of the upcoming market potential for Paclitaxel, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Paclitaxel sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Paclitaxel market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Paclitaxel sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma and Southpharma, etc.

Paclitaxel segment by Company
  • Phyton
  • ScinoPharm
  • Novasep
  • Samyang
  • Polymed
  • TAPI (Teva)
  • Fresenius-kabi
  • Huiang biopharma
  • Southpharma
  • Yunnan Hande
  • Hainan Yew Pharm
  • Jiangsu Yew Biotechnology
Paclitaxel segment by Type
  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API
Paclitaxel segment by Application
  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Others
Paclitaxel segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paclitaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paclitaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paclitaxel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Paclitaxel market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paclitaxel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Paclitaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Paclitaxel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Paclitaxel Market Size, 2019 VS 2023 VS 2030
1.3 Global Paclitaxel Market Size Estimates and Forecasts (2019-2030)
1.4 Global Paclitaxel Sales Estimates and Forecasts (2019-2030)
1.5 Global Paclitaxel Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives

2 GLOBAL PACLITAXEL MARKET DYNAMICS

2.1 Paclitaxel Industry Trends
2.2 Paclitaxel Industry Drivers
2.3 Paclitaxel Industry Opportunities and Challenges
2.4 Paclitaxel Industry Restraints

3 PACLITAXEL MARKET BY MANUFACTURERS

3.1 Global Paclitaxel Revenue by Manufacturers (2019-2024)
3.2 Global Paclitaxel Sales by Manufacturers (2019-2024)
3.3 Global Paclitaxel Average Sales Price by Manufacturers (2019-2024)
3.4 Global Paclitaxel Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Paclitaxel Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Paclitaxel Manufacturers, Product Type & Application
3.7 Global Paclitaxel Manufacturers Commercialization Time
3.8 Market Competitive Analysis
  3.8.1 Global Paclitaxel Market CR5 and HHI
  3.8.2 Global Top 5 and 10 Paclitaxel Players Market Share by Revenue in 2023
  3.8.3 2023 Paclitaxel Tier 1, Tier 2, and Tier

4 PACLITAXEL MARKET BY TYPE

4.1 Paclitaxel Type Introduction
  4.1.1 Natural Paclitaxel API
  4.1.2 Semi-synthetic Paclitaxel API
4.2 Global Paclitaxel Sales by Type
  4.2.1 Global Paclitaxel Sales by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Paclitaxel Sales by Type (2019-2030)
  4.2.3 Global Paclitaxel Sales Market Share by Type (2019-2030)
4.3 Global Paclitaxel Revenue by Type
  4.3.1 Global Paclitaxel Revenue by Type (2019 VS 2023 VS 2030)
  4.3.2 Global Paclitaxel Revenue by Type (2019-2030)
  4.3.3 Global Paclitaxel Revenue Market Share by Type (2019-2030)

5 PACLITAXEL MARKET BY APPLICATION

5.1 Paclitaxel Application Introduction
  5.1.1 Ovarian Cancer
  5.1.2 Cervical Cancer
  5.1.3 Breast Cancer
  5.1.4 Others
5.2 Global Paclitaxel Sales by Application
  5.2.1 Global Paclitaxel Sales by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Paclitaxel Sales by Application (2019-2030)
  5.2.3 Global Paclitaxel Sales Market Share by Application (2019-2030)
5.3 Global Paclitaxel Revenue by Application
  5.3.1 Global Paclitaxel Revenue by Application (2019 VS 2023 VS 2030)
  5.3.2 Global Paclitaxel Revenue by Application (2019-2030)
  5.3.3 Global Paclitaxel Revenue Market Share by Application (2019-2030)

6 GLOBAL PACLITAXEL SALES BY REGION

6.1 Global Paclitaxel Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Paclitaxel Sales by Region (2019-2030)
  6.2.1 Global Paclitaxel Sales by Region (2019-2024)
  6.2.2 Global Paclitaxel Sales Forecasted by Region (2025-2030)
6.3 North America
  6.3.1 North America Paclitaxel Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.3.2 North America Paclitaxel Sales by Country (2019-2030)
  6.3.3 U.S.
  6.3.4 Canada
6.4 Europe
  6.4.1 Europe Paclitaxel Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.4.2 Europe Paclitaxel Sales by Country (2019-2030)
  6.4.3 Germany
  6.4.4 France
  6.4.5 U.K.
  6.4.6 Italy
  6.4.7 Netherlands
6.5 Asia Pacific
  6.5.1 Asia Pacific Paclitaxel Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.5.2 Asia Pacific Paclitaxel Sales by Country (2019-2030)
  6.5.3 China
  6.5.4 Japan
  6.5.5 South Korea
  6.5.6 Southeast Asia
  6.5.7 India
  6.5.8 Australia
6.6 LAMEA
  6.6.1 LAMEA Paclitaxel Sales Growth Rate by Country: 2019 VS 2023 VS 2030
  6.6.2 LAMEA Paclitaxel Sales by Country (2019-2030)
  6.6.3 Mexico
  6.6.4 Brazil
  6.6.5 Turkey
  6.6.6 GCC Countries

7 GLOBAL PACLITAXEL REVENUE BY REGION

7.1 Global Paclitaxel Revenue by Region
  7.1.1 Global Paclitaxel Revenue by Region: 2019 VS 2023 VS 2030
  7.1.2 Global Paclitaxel Revenue by Region (2019-2024)
  7.1.3 Global Paclitaxel Revenue by Region (2025-2030)
  7.1.4 Global Paclitaxel Revenue Market Share by Region (2019-2030)
7.2 North America
  7.2.1 North America Paclitaxel Revenue (2019-2030)
  7.2.2 North America Paclitaxel Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
  7.3.1 Europe Paclitaxel Revenue (2019-2030)
  7.3.2 Europe Paclitaxel Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
  7.4.1 Asia-Pacific Paclitaxel Revenue (2019-2030)
  7.4.2 Asia-Pacific Paclitaxel Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
  7.5.1 LAMEA Paclitaxel Revenue (2019-2030)
  7.5.2 LAMEA Paclitaxel Revenue Share by Country: 2019 VS 2023 VS 2030

8 COMPANY PROFILES

8.1 Phyton
  8.1.1 Phyton Comapny Information
  8.1.2 Phyton Business Overview
  8.1.3 Phyton Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.1.4 Phyton Paclitaxel Product Portfolio
  8.1.5 Phyton Recent Developments
8.2 ScinoPharm
  8.2.1 ScinoPharm Comapny Information
  8.2.2 ScinoPharm Business Overview
  8.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.2.4 ScinoPharm Paclitaxel Product Portfolio
  8.2.5 ScinoPharm Recent Developments
8.3 Novasep
  8.3.1 Novasep Comapny Information
  8.3.2 Novasep Business Overview
  8.3.3 Novasep Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.3.4 Novasep Paclitaxel Product Portfolio
  8.3.5 Novasep Recent Developments
8.4 Samyang
  8.4.1 Samyang Comapny Information
  8.4.2 Samyang Business Overview
  8.4.3 Samyang Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.4.4 Samyang Paclitaxel Product Portfolio
  8.4.5 Samyang Recent Developments
8.5 Polymed
  8.5.1 Polymed Comapny Information
  8.5.2 Polymed Business Overview
  8.5.3 Polymed Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.5.4 Polymed Paclitaxel Product Portfolio
  8.5.5 Polymed Recent Developments
8.6 TAPI (Teva)
  8.6.1 TAPI (Teva) Comapny Information
  8.6.2 TAPI (Teva) Business Overview
  8.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.6.4 TAPI (Teva) Paclitaxel Product Portfolio
  8.6.5 TAPI (Teva) Recent Developments
8.7 Fresenius-kabi
  8.7.1 Fresenius-kabi Comapny Information
  8.7.2 Fresenius-kabi Business Overview
  8.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.7.4 Fresenius-kabi Paclitaxel Product Portfolio
  8.7.5 Fresenius-kabi Recent Developments
8.8 Huiang biopharma
  8.8.1 Huiang biopharma Comapny Information
  8.8.2 Huiang biopharma Business Overview
  8.8.3 Huiang biopharma Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.8.4 Huiang biopharma Paclitaxel Product Portfolio
  8.8.5 Huiang biopharma Recent Developments
8.9 Southpharma
  8.9.1 Southpharma Comapny Information
  8.9.2 Southpharma Business Overview
  8.9.3 Southpharma Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.9.4 Southpharma Paclitaxel Product Portfolio
  8.9.5 Southpharma Recent Developments
8.10 Yunnan Hande
  8.10.1 Yunnan Hande Comapny Information
  8.10.2 Yunnan Hande Business Overview
  8.10.3 Yunnan Hande Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.10.4 Yunnan Hande Paclitaxel Product Portfolio
  8.10.5 Yunnan Hande Recent Developments
8.11 Hainan Yew Pharm
  8.11.1 Hainan Yew Pharm Comapny Information
  8.11.2 Hainan Yew Pharm Business Overview
  8.11.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.11.4 Hainan Yew Pharm Paclitaxel Product Portfolio
  8.11.5 Hainan Yew Pharm Recent Developments
8.12 Jiangsu Yew Biotechnology
  8.12.1 Jiangsu Yew Biotechnology Comapny Information
  8.12.2 Jiangsu Yew Biotechnology Business Overview
  8.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Price, Revenue and Gross Margin (2019-2024)
  8.12.4 Jiangsu Yew Biotechnology Paclitaxel Product Portfolio
  8.12.5 Jiangsu Yew Biotechnology Recent Developments

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS

9.1 Paclitaxel Value Chain Analysis
  9.1.1 Paclitaxel Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 Manufacturing Cost Structure
  9.1.4 Paclitaxel Production Mode & Process
9.2 Paclitaxel Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 Paclitaxel Distributors
  9.2.3 Paclitaxel Customers

10 CONCLUDING INSIGHTS

11 APPENDIX

11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
  11.5.1 Secondary Sources
  11.5.2 Primary Sources
11.6 Disclaimer


More Publications